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Mycobacterium abscessus is a pathogenic, rapidly growing mycobacterium
responsible for pulmonary and cutaneous infections in immunocompetent
patients and in patients with Mendelian disorders, such as cystic fibrosis
(CF).Mycobacterium abscessus is known to transition from a smooth (S)morpho-
type with cell surface-associated glycopeptidolipids (GPL) to a rough (R)
morphotype lacking GPL. Herein, we show that M. abscessus S and R variants
are able togrow insidemacrophages andarepresent inmorphologicallydistinct
phagosomes. The S forms are found mostly as single bacteria within phago-
somes characterized by a tightly apposed phagosomal membrane and the
presence of an electron translucent zone (ETZ) surrounding the bacilli. By con-
trast, infectionwith theR form leads to phagosomes often containingmore than
twobacilli, surrounded bya loose phagosomalmembrane and lacking the ETZ.
In contrast to the R variant, the S variant is capable of restricting intraphagoso-
mal acidification and induces less apoptosis and autophagy. Importantly, the
membrane of phagosomes enclosing the S forms showed signs of alteration,
such as breaks or partial degradation. Although not frequently encountered,
these events suggest that the S form is capable of provoking phagosome–
cytosol communication. In conclusion, M. abscessus S exhibits traits inside
macrophages that are reminiscent of slow-growing mycobacterial species.
1. Introduction
TheMycobacterium genus represents a complex group ofmore than 100 species, of
which only a limited number are strict human or animal pathogens. Most of the
non-pathogenic saprophytic mycobacteria belong to the rapid-growing myco-
bacteria (RGM) group, although some of them, including M. abscessus,
M. chelonae and M. fortuitum, have recently been classified as true opportunistic
pathogens [1].Mycobacterium abscessus is now recognized as themajor pulmonary
pathogen within the RGM [2], with cystic fibrosis (CF) patients being particularly
vulnerable to infection with this mycobacterium [3–7].Mycobacterium abscessus is
& 2016 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution
License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, provided the original
author and source are credited.
also regarded as a nosocomial infectious agent responsible for
several epidemics due to clinical practices with contaminated
materials [8,9]. Recent epidemiological studies and clinical
case studies of CF patients infected with M. abscessus empha-
sized the persistence, sometimes for several decades, of
M. abscessus within the host [10–12]. Finally, M. abscessus has
been associated with the most direct impact on lung functions
in CF patients when compared with the slow-growing
mycobacterium (SGM) M. avium, and non-fermentative
Gram-negative bacteria [13].
Like M. avium or M. smegmatis [14], M. abscessus displays
two distinct morphotypes on solid agar media: a smooth (S)
variant, non-cording but motile and biofilm-forming, and a
rough (R) variant, cording but non-motile and non-biofilm-
forming. The major difference between these two variants
resides in the total loss of surface-associated glycopeptidolipids
(GPL) in the R form [15]. Importantly, the R variant appears to
arise only during the course of infection in the host organism, as
evidenced by culture-positive sputum samples from patients
[11] or experiments in B-cell-deficient mice [16]. In addition, R
variants are frequently associated with severe infections as
observed in CF patients infected with M. abscessus [11,12]. In
the light of these findings, one may hypothesize that S and R
variants differentially affect the phagocytic pathway.
Onekeydifference betweenpathogenic andnon-pathogenic
mycobacteria is the capacity of pathogenic mycobacteria to sur-
vive and replicatewithinmacrophages (Mf) and dendritic cells
(DC) by arresting phagosome maturation and, hence, prevent-
ing fusion with lysosomes [17–23]. Mycobacterium fortuitum
andM. smegmatis, a saprophytic RGM, are both unable to mul-
tiply inside Mf and are rapidly cleared from the infected cells
[24,25]. In sharp contrast, M. abscessus not only survives, but
also replicates inside Mf [26–28]. Histopathological studies
performed on autopsy-derived lung tissue sections of patients
who died from an infection with M. abscessus revealed the
presence of granulomaswith caseous lesions, a hallmark of per-
sistent mycobacterial infection [29]. Such characteristic features
have also recently been corroborated in zebrafish and mice
infected withM. abscessus [16,30].
Based on these physiopathological features, M. abscessus
can be regarded as a pseudotuberculous and virulent RGM
with a potential dual pathogenic manifestation linked to the
S to R transition. This prompted us to compare the phago-
cytic uptake and fate of both S and R variants within Mf
with respect to growth and describe how these events affect
the endomembrane compartment in which they reside. Our
findings point to intracellular characteristics that are specific
to M. abscessus S and which resemble those usually attributed
to pathogenic SGM.
2. Results
2.1. Differential phagocytic uptake of Mycobacterium
abscessus S and R variants
Bone-marrow-derived murine Mf (BMDM) were infected with
the S or R variant of M. abscessus at a multiplicity of infection
(MOI) of 1 in the absence of antibiotics (see Experimental
procedures). After extensive washes to eliminate the residual
extracellular bacteria, cells were fixed and processed for trans-
mission electron microscopy (TEM) at selected time points
thereafter (0–24 h p.i.). Examination of thin sections up
to 24 h p.i. showed that the S variant was efficiently phagocy-
tized. Bacteria in phagocytic cups or still binding to the
cell surface were usually not found with M. abscessus S
(figure 1a). Around 80% of the phagosomes harbouring
M.abscessusSwere lonerphagosomes containinga singlebacter-
iumwhereas 60% of the phagosomes harbouringM. abscessusR
were social phagosomes with at least 2 bacilli (electronic sup-
plementary material, figure S1). Most of the cell profiles
displayed between 1 and 10 phagosomes at 24 h p.i. By contrast,
the cell profiles displayed a low number of phagosomes follow-
ing infection with the R variant. This could be linked to the
highly aggregative nature of the R variant, despite extensive
treatments involving several passages through a syringe
needle. An important consequence of the R clumping/cording
is that, in many instances, bacteria were gathered in long
chains located at the close vicinity of the cell surface or in phago-
cytic cups. In the latter case, the tips of the pseudopods seemed
to be unable to fuse together to give rise to nascent phagosomes
(figure 1b). This observation indicates that a large amount of R
forms might remain outside the cells. A few phagosomes, how-
ever, were found within Mf. They usually harboured large
numbers of the M. abscessus R variant (figure 1c) as opposed
to those harbouring the S variant, usually containing a single
bacterium (figure 1d).
2.2. Mycobacterium abscessus multiplies similarly inside
wild-type and cystic fibrosis conductance
transmembrane regulator defective Mf
We next evaluated the intracellular growth of both variants in
murine and human Mf by infecting cells at an MOI of 1 for
3 h (see Experimental procedures). That M. abscessus S and R
survive in murine (figure 2a) and human (figure 2b) Mf is in
line with previous reports [26,28]. However, it was not poss-
ible to directly compare the data obtained for the S and R
variants because we systematically observed important
differences in the mycobacterial uptake (up to a one log10
difference for the R variant). Determination of bacterial
doubling time in Mf was 14.3+ 0.8 h for the R variant and
19.4+ 0.6 h for the S variant (figure 2a,b) compared with
6.0+0.6 h and 5.8+0.7 h for the in vitro grown R and S var-
iants, respectively (electronic supplementary material, figure
S2). These differences might be due to the intrinsic clumping
of the M. abscessus R variant (figure 1b,c), despite extensive
treatments to obtain homogeneous bacterial preparations
[21,31]. Although extracellular growth cannot be totally
excluded, this seems very unlikely because cells were system-
atically maintained under amikacin treatment during the
duration of the experiment.
Mycobacterium abscessus infection has been reported in
patients with CF, a genetic disease linked to a functional
defect of the CFTR (cystic fibrosis conductance transmembrane
regulator) chloride channel [32]. We therefore evaluated
whether mutations abolishing the expression level or function
and/or the stability of CFTRmay affectM. abscessus intracellu-
lar survival/growth. Comparison of the bacterial loads clearly
indicated that intracellular growth of the S and R variants was
similar inwild-type and cftr2/2 BMDM (figure 2c,d). Compar-
able results were obtained following infection of murine Mf
carrying the CFTRDF508 mutation, representing the most fre-
quent mutation encountered in CF patients and resulting in
an abnormal CFTRprotein (electronic supplementarymaterial,
rsob.royalsocietypublishing.org
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Figure 2. Growth of M. abscessus S (Mabs S) and R (Mabs R) variants in different cells. Wild-type murine (a) or human (b) Mf were infected with S and R variants.
Amikacin treatment was applied to avoid extracellular growth (see Experimental procedures). The number of CFU was determined at the indicated times p.i. (c,d )
Wild-type and cftr2/2 murine Mf were infected as mentioned above. Intracellular growth was similar in murine wild-type Mf and in murine Mf knock-out for
cftr (cftr2/2). Error bars indicate the s.e.m., based on the results from three independent experiments.
0.5 mm 0.5 mm
0.5 mm 0.5 mm
(b)(a)
(c) (d )
Figure 1. Ultrastructural differences of the M. abscessus S- or R-containing phagosomes. Bone marrow-derived murine Mf (BMDM) were infected with either the S (a,d )
or R (b,c) variants of M. abscessus for 3 h. At 24 h p.i., cells were fixed and processed for TEM. Thin sections were analysed for phagocytic uptake of each variant (a,b) and
the morphological appearance of R (c) or S (d )-containing phagosomes. S forms (a) reside within phagosomes and none are found in phagocytic cups whereas most of the
R forms (b) are still clustered in phagocytic cups (arrows) at 24 h p.i. (c) Once formed, the R-containing phagosomes usually comprise several bacteria (social phagosomes,
indicated with arrows). (d ) The S-containing phagosomes typically comprise a single bacterium (loner phagosomes, indicated with stars).
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figure S3). Overall, these observations not only indicate that
M. abscessus can resist the bactericidal activity of murine/
human Mf but also suggest that a functional CFTR is not
required for sustaining intracellular growth of M. abscessus, at
least within in vitro infected Mf.
2.3. Distinct morphology of the intraphagosomal
Mycobacterium abscessus S and R variants
The persistence phenotype of M. abscessus S and R in Mf
prompted us to examine their ultrastructure within phago-
somes. The most prominent feature was the appearance of
the mycobacterial cell wall and its interaction with the phago-
some membrane. In the case of the S strain, the outermost
electron translucent zone (ETZ), which is a major part of
the mycobacterial cell wall [33], was thick and apposed
to the phagosome membrane all around (figure 3a). By con-
trast, the R form displayed a very thin ETZ (figure 3b).
Although the phagosome membrane was no longer tightly
apposed to the mycobacterial cell wall all around, it did
seem to make contact with the mycobacterial cell wall at
discrete sites (figure 3b, arrows and insert).
It is well known that a major difference in the cell wall of
the S and R variants of M. abscessus and M. bolettii resides in
the lack of GPLs in the outermost cell wall layer of the R var-
iant [34,35]. To confirm the dependence of ETZ formation on
GPL production, BMDM were infected with a DmmpL4b
mutant generated in an S background, a well-defined
mutant that fails to produce and export GPL but exhibits a
clumping/cording phenotype similar to the wild-type R
strain [34]. BMDM were also infected with the corresponding
complemented strain expressing mmpL4b under the control of
the hsp60 promoter on the pNVB1 integrative plasmid [36].
Only the wild-type M. abscessus S and the DmmpL4b comple-
mented strain, both producing GPLs, elaborated a thick ETZ
(figure 3a,c), whereas the GPL-deficient DmmpL4b mutant,
like the R variant, did not (figure 3b,d ). Overall, these results
indicate that M. abscessus elaborates an ETZ that depends on
GPL production, which might contribute to the survival of
the S variant within its host cell.
2.4. Mycobacterium abscessus S prevents phagosome
maturation/acidification
Based on the intracellular survival of the twovariants, it was of
importance to understand by which mechanism(s) they resist
the bactericidal response, known to clearmost RGM infections.
Live pathogenic mycobacteria, but not avirulent mycobacteria,
are known to be retained in a mildly acidified environ-
ment [17,37–39]. The measurement of the phagosomal pH,
following internalization, has been widely used as a physio-
logically relevant indicator of the maturation status of
phagosomes [40]. We therefore analysed the pH of S- versus
R-containing phagosomes in Mf using direct measurement
of intraphagosomal pH by double fluorescent labelling. FITC
(pH sensitive)-labelledM. abscessus S or R expressingmCherry
(pH resistant) were used to infect Mf. The ratio between
pH-sensitive and pH-resistant fluorescent stains was scored
at specific time points. The pHwas then calculated by compar-
ing each ratio against a pH standard curve established with
well-defined pH buffers [40]. Mycobacterium abscessus S- and
M. marinum-containing phagosomes were not acidified in
murineMf, as reported forM. tuberculosis orM. avium infected
cells [17,37] (figure 4). That heat-killed M. abscessus S failed to
prevent phagosomal acidification suggests that this relies on
an active process. Conversely, M. abscessus R-containing pha-
gosomes were significantly more acidic than those containing
the S variant at all time points (figure 4). A fast decline in pha-
gosomal pH was previously reported to correlate with the
rapid processing of phagosomes in late phagosomes or phago-
lysosomes [41]. This establishes that M. abscessus S-containing
phagosomes are not processed into phagolysosomes follow-
ing infection as shown earlier for phagosomes containing
pathogenic mycobacteria [17,23,42–44].
2.5. The S variant may induce phagosome-cytosol
communication
Both in vitro and in vivo studies demonstrated that pathogenic
M. tuberculosis and M. marinum induce ruptures in the
phagosome membrane and establish a phagosome-to-cytosol
communicationprior to thehost cell death [45–48].Weevaluated
whether this may also occur forM. abscessus.Conventional TEM
approacheswere first used to investigatewhether the S formwas
able to promote an alteration of the phagosomal membrane,
eventually followed by rupture of the membrane, which would
allow the S form to gain access to the cytosol. Phagosomal rup-
ture and phagosome-cytosol communication can be difficult to
assess by conventional TEM because of tangential sections
through part or all of thephagosomemembrane. Carewas there-
fore taken to examine only parts of the phagosome membrane
ETZ
0.5 mm 0.5 mm
0.5 mm0.5 mm
(b)(a)
(c) (d )
Figure 3. Morphological appearance of the electron translucent layer (ETZ) of
the cell wall of M. abscessus within phagosomes. Bone marrow-derived
murine Mf (BMDM) were infected with various M. abscessus strains for 3 h.
At selected time points p.i., cells were fixed and processed for TEM. The cell
wall ultrastructure of the different strains was assessed on 100–200 different
bacterial profiles. (a) S variant: the electron translucent outermost layer (ETZ)
of the wall was thick and apposed to the smooth phagosome membrane
(arrows) all around. (b) R variant: in the absence of GPL production, the ETZ
was thin and the phagosome membrane had a wavy appearance (arrows); in
some instances a close contact was observed at discrete sites (arrow and
insert). (c) Mycobacterium abscessus DmmpL4b complemented strain: as for
the S variant. (d ) Mycobacterium abscessus DmmpL4b mutant: no GPL produced
and thin ETZ as for the R variant.
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where theplaneof the sectionwasperpendicular to themycobac-
terial cell wall and hence also the phagosome membrane. Four
situations were observed at 24 h p.i., as follows. (i) In the first
and most frequent case, the phagosome membrane had a
smooth appearance and it was tightly apposed to the ETZ
(figure 5a, arrows). (ii) For part of the phagosomes, the mem-
brane became wavy and it was no longer closely apposed to
the ETZ (figure 5b, arrow). This could represent the first sign of
an alteration of the phagosomalmembrane. (iii) In rare instances,
interruptions in the phagosome membrane were observed
0 15 30 45 60 75 90 105 120
4.8
5.2
5.6
6.0
6.4
6.8
7.2
7.6
time (min)
pH
Mabs S
Mabs S heat-killed
M. smegmatis
Mabs R
M. marinum
**
Figure 4. Absence of phagosomal acidification insideM. abscessus S-infected Mf. Human THP-1 Mf were infected with FITC-labelled mCherry-expressingM. abscessus S
(Mabs S) and R (Mabs R),M. smegmatis, M. marinum and heat-killed M. abscessus S (Mabs S heat-killed). Fluorescent signals were measured sequentially at 485 nm (FITC)
and 544 nm excitation wavelengths (mCherry) after a 15 mn incubation period at 378C. The first time point on the x-axis (0 mn) was taken immediately after the 15 mn
incubation. Subsequently, the pH at each time point was extrapolated from a standardized pH curve. The pH values were significantly different depending on whether
phagosomes contained S or R variants. Results are representative of three independent experiments. (**p, 0.01).
0.5 mm
0.5 mm
0.5 mm 0.5 mm
(b)
(a)
(c) (d )
Figure 5. Alteration of the membrane of phagosomes containing the S variant as assessed by TEM. Bone marrow-derived murine Mf were infected with M. abscessus S
for 3 h. Phagosomes were examined for obvious signs of membrane alteration/destruction. (a) No alteration: the phagosome membrane is smooth (arrows) and closely
apposed to the mycobacterial cell wall ETZ all around. (b) First sign of alteration: the phagosome membrane has become wavy and is no longer closely apposed to the
bacterium all around (arrows). (c) The phagosome membrane displays breaks (arrowheads). (d ) The phagosome membrane is no longer visible (stars).
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(figure 5c, arrowheads) thatwerenot observed in other endocytic
organelles (not shown). (iv)Finally, inafewcases, thephagosome
membrane was no longer visible around part of the bacterium
(figure 5d). Owing to the above-mentioned constraints, it was
not possible by TEM to determine whether the entire bacterium
hadbeen freed in thecytosol (complete ruptureof thephagosome
membrane) or not (phagosome–cytosol communication only)
and quantifications were not possible for the same reasons.
Phagosome membrane rupture was subsequently assessed
using the CCF-4 (cephalosporin core linking 7-hydroxycou-
marin to fluorescein) substrate in a fluorescence resonance
energy transfer (FRET) assay, as previously described [47]. Dif-
ferentiated THP-1 cells infected at an MOI of 1, either with
M. abscessus S,M. smegmatis (negative control) or M. marinum,
displayed at day 0 (3 h p.i.) a FRET 450 nm (blue)/535 nm
(green) ratio of 1 (electronic supplementary material,
figure S4), indicative of an absence of CCF-4 cleavage by
the M. abscessus b-lactamase (BlaMab) [48]. Interestingly,
and in contrast to M. smegmatis-infected Mf, M. abscessus
S-infected cells displayed a FRET ratio of 1.5 at 24 h p.i., indica-
tive of the fluorescence shift as a result of the disruption of
CCF-4 by BlaMab in the cytosolic compartment (electronic sup-
plementary material, figure S4). The FRET assay, performed in
THP-1 cells, relies either on phagosome–cytosol interplay
enabling diffusion of BlaMab into the cytosol and/or on the
presence of free intra-cytosolic organisms. These results corro-
borate the TEM observations in murine Mf and suggest that
the S variant, but not the R form, might establish a successful
phagosome–cytosol communication.
2.6. Mycobacterium abscessus S fails to trigger
apoptosis and bacterial autophagy
The phagosome–cytosol interplay may substantially impact
on apoptosis and autophagy in the infected host phagocytes
[49], both these cellular responses being efficient in controlling
the intracellular growth of the RGM, M. smegmatis and M. for-
tuitum [24,50,51]. Here, we evaluated the extent of apoptosis
following infection of THP-1MfwithM. abscessus S, following
annexin-V labelling. M. smegmatis, known as a potent apopto-
sis-inducing species [24,25], was also included as a positive
control. Our results confirm the previously described pro-
apoptotic activity of M. smegmatis [25] with nearly 80% of
infected cells annexin-V-positive at 24 h p.i. (figure 6a). Com-
pared to M. smegmatis, M. abscessus S- and R-infected Mf
were only slightly apoptotic, with at most 10% of infected
cells annexin-V-positive at 24 h (figure 6a). However, a signifi-
cant difference in labelling was observed between the S and R
variants at 48 h p.i. (figure 6a) with 50% and 90%of annexin-V-
positive infected Mf, respectively. Overall, these results indi-
cate that M. abscessus S is less pro-apoptotic than M. abscessus
R, in agreement with previous observations in zebrafish [30].
Autophagy was next assessed after infection of THP-1
Mf with the Alexa488-labelled S variant and using anti-
LC3-antibodies to specifically immunolabel autophagosome
membranes. M. abscessus S did not co-localize with the
LC3 marker, with 10% at 24 h p.i. of autophagosomes poten-
tially containing the S variant (figure 6b,c). Comparatively,
the R variant induced more autophagy than the S variant
(figure 6b,c), as evidenced by the increased percentage of
M. abscessus-LC3-positive infected cells (figure 6b) and confocal
microscopy (figure 6c). In addition, the results obtained with
the GPL-deficient DmmpL4b S mutant were comparable to
those of M. abscessus R (figure 6b), confirming the importance
of the surface-exposed GPL in the inhibition of autophagy of
the S variant.
3. Discussion
The source and the mechanism responsible for pulmonary
contamination of CF patients with M. abscessus remain
unclear [52]. It appears, therefore, critical to understand how
M. abscessus resists the Mf bactericidal activity, usually
highly efficient against other RGM, such as M. smegmatis and
M. fortuitum [24,25]. The S variant, capable of forming bio-
film-like structures, is most likely to be the infecting form.
GPL present at the surface of M. abscessus S have been shown
to prevent TLR2 signalling in respiratory epithelial cells [53],
possibly allowing lung colonization and subsequent survival
in a silent and permissive niche, as shown for M. tuberculosis
andM.marinum [20,45]. Herein,we confirmed thatM. abscessus
S survives in Mf, an observation consistent with previous
studies [26–28], and demonstrated, for the first time, that repli-
cation of M. abscessus in Mf was not affected by functional
CFTR defects. This provides evidence that such a modification
is not responsible for the peculiar susceptibility of CF patients
to M. abscessus infections, at least at the intracellular level.
Noteworthily, Griffith et al. demonstrated that one third of
the pulmonary infections due to M. abscessus can occur in the
absence of a pre-existing lung pathology [2], emphasizing
the intrinsic ability of M. abscessus to resist the bactericidal
activity of Mf, a feature historically considered to be an exclu-
sive attribute of SGM. In this context, Oberley-Deegan et al.
proposed that M. abscessus could interfere with phagosome
processing into phagolysosomes through the manipulation of
host signal transduction pathways [27,54].
After phagocytosis byMf, the S variant is found as a single
bacterium in loner phagosomes whose membrane is closely
apposed all around the outer surface of the mycobacterial
cell wall. The S variant was also found to reside in slightly acid-
ified non-mature phagosomes that are unable to fuse with
lysosomes [42,43]. The retention of Rab5 at the membrane of
M. abscessus-containing phagosomes in epithelial cells [54] is
consistent with these findings. In addition, M. abscessus S was
also found to be a poor apoptosis- and autophagy-inducing
strain. These results were unexpected as all the RGM studied
so far, particularly M. smegmatis and M. fortuitum, reside in
phagolysosomes and are subsequently eliminated by the Mf.
Moreover, RGM are known to induce the formation of autop-
hagic vacuoles and cell apoptosis, both strategies considered
important host cell defence mechanisms [55–57].
By contrast, the R form follows a rather different pathway.
First, during the early infection stage, it presents a strong
tendency to form chains or large clumps that usually remain
in phagocytic cups instead of being internalized. As a result,
cells contain less phagosomes but the latter contain generally
multiple bacteria. It is well known that phagosomes containing
several bacteria are systematically processed into phago-
lysosomes [17,23,41–44]. As expected, such phagosomes were
rapidly acidified. Yet the intraphagosomal R variants did not
appear to undergo degradation, at least during the first 24 h
p.i., as assessed by EMobservation of thin sections. The absence
of degradation in phagolysosomes has already been observed
for other mycobacteria [42]. Furthermore, the presence of the
rsob.royalsocietypublishing.org
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RvariantwithinMf induced the formation of autophagic vacu-
oles and cells became apoptotic. All these results point towards
a typical RGM-like behaviour for the R variant [24,25]. It is note-
worthy that the potent apoptosis-induced cell death activity
may help the R variant to reach the extracellular environment
([30] and our study) where it can form cords. However, another
unexpected result of this study was that the R variant, as
opposed to other RGM, was able to replicate within Mf, an
intriguing phenotype that may be due to the extensive clump-
ing of the R variant within phagocytic cups or phagosomes.
Moreover, re-invasion of extracellular bacteria that are released
from the apoptotic Mf cannot be fully excluded.
The question that arises from this work is the following:
why do the R and S variants follow such different phago-
some trafficking pathways? Based on EM analyses of murine
Mf infected with either M. avium, or M. tuberculosis, de
Chastellier and colleagues showed evidence that, independent
of the molecular mechanisms involved in the blocking of
phagosome maturation of a mycobacterium-containing
phagosome, the establishment and maintenance of a close
apposition of the phagosome membrane with the entire myco-
bacterial surface all around represented a necessary
requirement for prevention of phagosome maturation [39,42].
Interestingly, such a close interaction was observed in the
case of S variant-containing phagosomes but not for those con-
taining the R form. The establishment and maintenance of a
long-lasting close apposition most probably involves the inter-
action between specific proteins and/or lipids of the
phagosome membrane with specific components of the myco-
bacterial cell wall surface. Among these, ManLAM of M.
tuberculosis is considered to be responsible for the prevention
of phagosome maturation [58]. Recent studies also demon-
strated that cyclopropane rings in a-mycolic acids are critical
determinants for the phagosome maturation block [59]. The
masking role of phenolic glycolipid (PGL), a major glycolipid
found in SGM, includingM. marinum and someM. tuberculosis
clinical isolates, for recruiting permissive Mf has also been
unravelled [60]. By analogy, GPL can be regarded as the
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Figure 6. Mycobacterium abscessus-induced apoptosis and autophagy in wild-type Mf. (a) Analysis of apoptosis: THP-1 Mf were infected with M. abscessus
S (Mabs S), M. abscessus R (Mabs R) or M. smegmatis (MS). The percentage of apoptotic cells was determined at 24 h p.i. using annexin-V-FITC conjugates
(Abcam, USA) and propidium iodide to stain the dead cells. Fluorescent signals (mCherry from mycobacteria, FITC from the annexin-V and absence of propidium
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PGL-matching glycolipid of atypical mycobacteria as it dis-
plays similar functional roles, such as limiting mycobacterial
uptake [61] andmasking the TLR2 ligands, thereby accounting
for different inflammation-elicited responses towards S and R
variants [36,62]. It could thus be argued that the S to R tran-
sition, involving loss of function mutations in the GPL
biosynthetic or export machinery in M. abscessus, conditions
the inflammatory response of the infected host.
The EM approaches used in this work provide compelling
evidence on the role ofGPL in the differential processing of pha-
gosomes containing the S and R variants. It is well known that
GPL is a major constituent of the mycobacterial cell wall ETZ
[63,64].While the ETZwasvery thick in the case of the S variant,
itwas thinned out in the case of theRvariant and also in the case
of the DmmpL4b mutant that is unable to transport/assemble
GPL at the bacterial surface. With the S variant being closely
apposed to the phagosome membrane all around, and the R
variant making contact with the phagosome membrane only
at discrete sites, it is tempting to speculate that GPL is a major
actor for establishing and maintaining the close apposition
required for prevention of phagosome maturation. In fact, the
M. avium complex GPL can delay phagosome–lysosome
fusion following its ligation to the mannose receptor [65,66].
Interestingly, among M. abscessus, M. smegmatis and
M. chelonae, all expressing cell surface GPL, as evidenced by
high conservation of their respective gpl locus [67], only
M. abscessus andM. chelonae have retained the ability to survive
inside Mf [68]. Mycobacterium smegmatis mc2155 strain, which
derives originally from the ATCC 607 strain [69], expresses
less triglycosylated GPL than M. abscessus or M. chelonae [67].
That the level ofGPLproduction can be enhanced inM. smegma-
tismc2155when overexpressing thewholembtH-mps1-mps2-gap
operon fromM. abscessus [70] reflects quantitative differences in
GPLproduction between these species, despite thepresence of a
similar gpl locus. Subtle differences at the cell surface in relation
to GPL production may thus considerably interfere andmodify
the fate of mycobacteria within Mf.
Another important aspect concerns the possibility for M.
abscessus to alter the phagosomal membrane and free itself
fromthephagosome inwhich it resides.Aqualitative EManaly-
sis of thin sections of at least 150 phagosomes showed that the
membrane of S- but not R-containing phagosomesmay present
alterations. The membrane became loose and, in rare instances,
showed breaks or partial lysis. Importantly, neighbouring orga-
nelles showed no signs of membrane alteration, thus ruling out
eventual artefacts due to the processing of the EM samples.
Unfortunately, we were neither able to quantify such events
nor to conclusively determine whether the entire bacterium
could be released into the cytosolic compartment.
The mycobacterial constituents and molecular mechanisms
involved in the alteration or rupture of the M. abscessus
S-containing phagosome membrane remain unknown. It has
been reported that M. abscessus is not equipped with the
ESX-1 apparatus, which mediates establishment of cytosol
contact for slow-growing pathogenic mycobacteria such as
M. tuberculosis [46,47,55,71,72],M. marinum [45] andM. kansasii
[73]. Ongoing work dedicated to study a panel of defined
transposon mutants [74] will hopefully allow us to identify
the putative ESX-1-independent membrane-damaging con-
stituents of the S strain, which are obviously mediated by an
ESX-1-independent mechanism.
To summarize, it seems to be rather difficult to strictly com-
pare the behaviours of S and R morphotypes. S and R variants
can be regarded as two representatives of the same isolate,
which coexist and/or evolve differently in response to host
immunity, resulting in different fates for both the bacteria
and the host. In conclusion, we provide compelling evidence
that, at the cellular level,M. abscessus S imitates the phenotypic
traits of pathogenic SGM and that the loss of cell wall associ-
ated lipids, namely GPL, can result in the acquisition of an
RGM-like intracellular behaviour with a peculiar extracellular
state characterized by a very high replication capacity [30].
CF patients are mainly infected with extracellular pathogens,
such as Pseudomonas and Staphylococcus, with high growth
rates in the bronchial lumen. By analogy, M. abscessus R can
be regarded as the aggressive form in these patients. The
capacity of M. abscessus to transition from an S intra-Mf-
resistant form to an R extracellular form probably increases
its capacity to adapt and survive in the changing environ-
ments. This is corroborated by recent comparative genomic
studies indicating that M. abscessus evolves rapidly and
should be monitored closely for the acquisition of more patho-
genic traits. Mycobacterium abscessus genomes are very plastic,
with many recently introduced insertion sequences such
as prophages and novel genes, and have an open pan-
genome [75,76], suggesting that they might continue to
acquire new genetic material, for the adaptation to divergent
environmental conditions.
4. Experimental procedures
4.1. Bacterial culture conditions
Isogenic pairs of S and R GFP- or mCherry-expressing
M. abscessus CIP 104536T were used throughout this study. An
mmpL4b KO (DmmpL4b) mutant displaying an R morphotype
[34] and its complemented counterpart, which stably expresses
MmpL4b under the control of the hsp60 promoter, were also
used. Mycobacteria were grown aerobically in Middlebrook
7H9 medium supplemented with 0.05% Tween 80 and 10%
OADC (oleic acid, dextrose, catalase and bovine albumin)
(Becton Dickinson, Le Pont-de-Claix, France) at 378C. GFP-
expressing strains were propagated in medium containing
500 mg ml21 hygromycin B (Roche Diagnostics, Meylan,
France). MCherry-expressing mycobacterial strains were
grown in the presence of 250 mg ml21 kanamycin (Sigma, USA).
4.2. Macrophage culture conditions
Animal experiments were performed according to institutional
and national ethical guidelines (Agreement no 92-033-01).
DF508 FVB mice, supplemented with movicol (Norgine, The
Netherlands), and their wild-type FVB littermates [77,78] were
from INRA (Jouy en Josas, France). The BMDM Mf, human
monocyte- derivedMf (HMDM)andTHP-1Mfwereprepared
as previously described [31,79]. THP-1 Mf were cultured in
RPMI 1640 supplemented with 10% FBS and differentiated for
24 h with 20 ng ml21 PMA prior to infection.
4.3. Mf infections and intracellular growth
measurement
Mycobacteria, grown aerobically at 378C up to mid-log phase,
were harvested by centrifugation and suspended in a phos-
phate buffer saline (PBS) solution (Sigma, USA). The bacterial
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clumpswere disrupted by 20–30 passages through 26.5G insu-
lin syringe and the bacterial suspension was then used to infect
Mf (5  104 to 105) at an MOI between 1 and 10 mycobacteria
per Mf in order to avoid rapid cell lysis, and incubated for 3 h
at 378C. After infection, cells were washed thoroughly with
PBS (three to four times, except when explicitly stated differ-
ently) to eliminate extracellular bacteria and re-fed with
complete medium containing amikacin at 250 mg ml21
(except for EM experiments) for a further 1 h incubation at
378C. This step was essential for killing the remaining extra-
cellular mycobacteria, particularly the R variant that presents
a sticky and clumpy phenotype (see Results). Themedium con-
taining amikacin was then discarded and cells were washed
again three times. Infected cells were subsequently incubated
in the presence of amikacin at 50 mg ml21 at 378C (except for
EM experiments). CFU counts were performed at day 0 (or
4 h p.i. after the last wash), day 1, day 3 and day 5, by lysing
the cells with cold distillated water, and plating 10-fold serial
dilutions on LB plates (Sigma, USA). Colony enumeration
was performed after 5–7 days of incubation at 378C.
4.4. Analysis of phagosomal acidification
In total, 24-well plates of fully confluent monolayers of Mf
were infected with FITC-labelled M. abscessus (expressing
mCherry) at an MOI between 1 and 10, centrifuged at low
speed for 90 s and incubated at 378C for 15 min prior to flu-
orescence measurements. Fluorescent signals were then
measured by sequentially exciting at 485 nm (FITC) and
544 nm (mCherry) using a Fluoroskan Ascent FL spectrofluo-
rometer (Thermo Fisher Scientific, France). A standard pH
curve was established to correlate the fluorescence signal
with the pH as described [40].
4.5. Apoptotis and autophagy determination
The apoptosis assay was performed as described previously
[80]. Mf were infected with M. abscessus and the percentage
of apoptotic cells was determined using annexin-V–FITC
conjugates (Abcam, USA) and propidium iodide staining of
dead cells. Cells were infected with mCherry-expressing
mycobacteria at an MOI of 10. For flow cytometry analysis,
10 000 events were collected for each condition and the
percentages of annexin-V-positive mCherry-positive and pro-
pidium iodide-negative cells were determined, in order to
count infected cells that became apoptotic.
For autophagy, mycobacteria were labelled with
50 mg ml21 Alexa-488-succinimidyl ester in PBS for 45 min at
room temperature (RT) and used to infect THP-1 Mf at an
MOI of 1–10. Cells were spun down for 5 min at 800 rpm to
synchronize phagocytosis, incubated for 30 min at 378C,
washed several times to remove extracellular bacteria and
then incubated for 15 min, 2 h or 24 h at 378C. Subsequently,
cells were fixedwith 2%paraformaldehyde (Deltamicroscopy)
for 10 min, permeabilized with 0.1% Triton X100/PBS for
5 min and blocked with 4% BSA (Euromedex, France), 2%
goat serum (Sigma, USA) in PBS for 1 h. Cells were incubated
with rabbit anti-LC3 (MBL, France) overnight in blocking
buffer, washed and then incubated for 3 hwith secondary anti-
body coupled to Alexa-568. Observation was done using a
Zeiss LSM 510 Inv confocal microscope and images were pro-
cessed with IMAGEJ software. A total of 100 bacteria were
counted per time point.
4.6. Processing for electron microscopy
Cells were fixed for 1 h at RT with 2.5% glutaraldehyde
(Sigma, St Louis, MI, USA) in 0.1 M cacodylate buffer, pH
7.2, containing 0.1 M sucrose, 5 mM CaCl2 and 5 mM
MgCl2. After two successive 15min washes with the same
buffer, cells were post-fixed for 1 h at RT with 1% osmium
tetroxide (Electron Microscopy Sciences, distributed by Euro-
medex, Mundolsheim, France) in the same buffer devoid of
sucrose. Cells were washed with buffer, scraped off the
dishes with a rubber policeman, concentrated in 2% agarose
in the same buffer, and treated for 1 h in 1% uranyl acetate in
30% methanol. Samples were dehydrated in a graded series
of ethanol and embedded in Spurr resin. Thin sections were
stained with 1% uranyl acetate in distilled water and then
with lead citrate.
4.7. Fluorescence resonance energy transfer
We performed a modified assay that was previously used to
investigate the breakdown of the endocytic vacuoles by
Gram-negative bacteria using a chemical probe that is trapped
within the host cytoplasm and detectable by fluorescence res-
onance energy transfer (FRET) measurements, as recently
described [47]. Briefly, at successive stages of the time course
measurements, a mix containing 50 mM CCF-4 substrate (Life
Technologies, Saint Aubin, France) in EM medium (120 mM
NaCl, 7 mM KCl, 1.8 mM CaCl2, 0.8 mM MgCl2, 5 mM glu-
cose and 25 mM Hepes at pH 7.3) containing 2.5 mM
probenicid was added to the infected THP-1 cells for 2 h at
RT in the dark. Cells were then washed with PBS containing
2.5 mM probenicid before fixing with PFA 4% for 30 min at RT
in the dark. Cellswerewashed directly before performing fluor-
escence imaging. Measurement of the ratio of 450 nm (blue)/
535 nm (green) fluorescence allowed determining whether the
bacteria established a phagosome–cytosol communication.
Reading was performed by a fluorescence microscope with
AutoPlay (Nikon) for the automatic acquisition of at least
50 cells per well and image analyses were performed using
a dedicated algorithm using METAMORPH software [47]. The
experiment was repeated twice with similar results.
4.8. Statistical analyses
Fisher’s exact test and the Student’s t-test were used for
all comparisons (GraphPad PRISM version 6.0d; GraphPad
Software, Inc). A p-value less than 0.05 was considered
significant (n.s. ¼ non-significant, *p, 0.05; **p, 0.01;
***p, 0.001; ****p, 0.0001).
Authors’ contributions. A.-L.R., A.V., A.B., R.S., A.B., L.L., T.D., L.M., M.R.
and F.G.-M. carried out the microbiology, bacterial–cells interaction,
confocal microscopy, electronic microscopy (A.V. with C.d.C.).
J.-L.H., L.K., C.d.C., I.V., R.B., L.M. and J.-L.G. participated in the
design of the study and drafted the manuscript; A.-L.R., A.B., R.S.,
L.M., I.V., R.B. and J.-L.H. carried out the statistical analyses;
J.-L.H., L.K., R.B., C.d.C. and I.V. conceived the study, designed the
study, coordinated the study and drafted the manuscript. All authors
gave final approval for publication.
Competing interests. We have no competing interests.
Funding. This workwas supported by the French Cystic Fibrosis Patients
Association ‘Vaincre la Mucoviscidose’ (IC0709; IC0808; IC1010) and
the French Research National Agency (ANR program DIMIVYR
(ANR-13-BSV3-0007-01). R.B. acknowledges support by the Fondation
Pour La Recherche Me´dicale FRM (DEQ20130326471). L.K. acknowl-
edges the FRM (DEQ20150331719). I.V. was supported by a
rsob.royalsocietypublishing.org
Open
Biol.
6:
160185
9
European Community FP7 Marie Curie Career Integration Grant
Europe (autophagtuberculosis 293416), University of Toulouse and
Vaincre la Mucoviscidose. A.V. would like to thank Infectiopoˆle Sud
for financial support. C.d.C. and A.V. performed the EM observations
and analyses in the PiCSL EM core facility (Institut de Biologie du
De´veloppement/Aix Marseille Universite´, Marseille), a member of
the France-BioImaging French research infrastructure.
Acknowledgements. We greatly acknowledge Dr S. Canaan for critical
reading of the manuscript and help in formatting the TIFF files of
EM figures and V. Dubois for formatting the figures. We wish to
acknowledge TRI-Genotoul Imaging facility (Toulouse, France). The
authors wish to thank Jean Paul Chauvin, head of this EM facility,
for expert technical assistance with the electron microscopes and
the digital camera.
References
1. Guglielmetti L et al. 2015 Human infections due to
nontuberculous mycobacteria: the infectious
diseases and clinical microbiology specialists’ point
of view. Future Microbiol. 10, 1467–1483. (doi:10.
1111/j.1462-5822.2005.00675.x)
2. Griffith DE, Girard WM, Wallace RJJ. 1993 Clinical
features of pulmonary disease caused by rapidly
growing mycobacteria. An analysis of 154 patients.
Am. Rev. Respir. Dis. 147, 1271–1278. (doi:10.
1164/ajrccm/147.5.1271)
3. Olivier KN et al. 2003 Nontuberculous mycobacteria.
I: Multicenter prevalence study in cystic fibrosis.
Am. J. Respir. Crit. Care Med. 167, 828–834.
(doi:10.1164/rccm.200207-678OC)
4. Levy I et al. 2008 Multicenter cross-sectional
study of nontuberculous mycobacterial
infections among cystic fibrosis patients, Israel.
Emerg. Infect Dis. 14, 378–384. (doi:10.3201/
eid1403.061405)
5. Roux A-L et al. 2009 Multicenter study of
prevalence of nontuberculous mycobacteria in
patients with cystic fibrosis in france. J. Clin.
Microbiol. 47, 4124–4128. (doi:10.1128/JCM.
01257-09)
6. Esther CRJ, Esserman DA, Gilligan P, Kerr A, Noone
PG. 2010 Chronic Mycobacterium abscessus infection
and lung function decline in cystic fibrosis. J. Cyst
Fibros. 9, 117–123. (doi:10.1016/j.jcf.2009.12.001)
7. Qvist T et al. 2015 Epidemiology of nontuberculous
mycobacteria among patients with cystic fibrosis in
Scandinavia. J. Cyst Fibros. 14, 46–52. (doi:10.
1016/j.jcf.2014.08.002)
8. Duarte RS et al. 2009 Epidemic of postsurgical
infections caused by Mycobacterium massiliense.
J. Clin. Microbiol. 47, 2149–2155. (doi:10.1128/
JCM.00027-09)
9. Lea˜o SC et al. 2010 Epidemic of surgical-site
infections by a single clone of rapidly growing
mycobacteria in Brazil. Future Microbiol. 5,
971–980. (doi:10.2217/fmb.10.49)
10. Cullen AR, Cannon CL, Mark EJ, Colin AA. 2000
Mycobacterium abscessus infection in cystic fibrosis.
Colonization or infection? Am. J. Respir. Crit Care
Med. 161, 641–645. (doi:10.1164/ajrccm.161.2.
9903062)
11. Jonsson BE, Gilljam M, Lindblad A, Ridell M,
Wold AE, Welinder-Olsson C. 2007 Molecular
epidemiology of Mycobacterium abscessus,
with focus on cystic fibrosis. J. Clin. Microbiol. 45,
1497–1504. (doi:10.1128/JCM.02592-06)
12. Catherinot E et al. 2009 Acute respiratory failure
involving an R variant of Mycobacterium abscessus.
J. Clin. Microbiol. 47, 271–274. (doi:10.1128/JCM.
01478-08)
13. Qvist T et al. 2016 Comparing the harmful effects of
nontuberculous mycobacteria and Gram negative
bacteria on lung function in patients with cystic
fibrosis. J. Cyst Fibros. 15, 380–385. (doi:10.1016/j.
jcf.2015.09.007)
14. Chatterjee D, Khoo KH. 2001 The surface
glycopeptidolipids of mycobacteria: structures
and biological properties. Cell Mol. Life Sci. 58,
2018–2042. (doi:10.1420-682X/01/142018-25)
15. Howard ST, Rhoades E, Recht J, Pang X, Alsup A,
Kolter R, Lyons CR, Byrd TF. 2006 Spontaneous
reversion of Mycobacterium abscessus from a
smooth to a rough morphotype is associated
with reduced expression of glycopeptidolipid
and reacquisition of an invasive phenotype.
Microbiology 152, 1581–1590. (doi:10.1099/
mic.0.28625-0)
16. Rottman M, Catherinot E, Hochedez P, Emile J-F,
Casanova J-L, Gaillard J-L, Soudais C. 2007 Importance
of T cells, gamma interferon, and tumor necrosis factor
in immune control of the rapid grower Mycobacterium
abscessus in C57BL/6 mice. Infect Immun. 75,
5898–5907. (doi:10.1128/IAI.00014-07)
17. de Chastellier C, Lang T, Thilo L. 1995 Phagocytic
processing of the macrophage endoparasite,
Mycobacterium avium, in comparison to
phagosomes which contain Bacillus subtilis or latex
beads. Eur. J. Cell Biol. 68, 167–182.
18. Sturgill-Koszycki S, Schaible UE, Russell DG. 1996
Mycobacterium-containing phagosomes are
accessible to early endosomes and reflect a
transitional state in normal phagosome biogenesis.
EMBO J. 15, 6960–6968.
19. Via LE, Deretic D, Ulmer RJ, Hibler NS, Huber LA,
Deretic V. 1997 Arrest of mycobacterial phagosome
maturation is caused by a block in vesicle fusion
between stages controlled by rab5 and rab7. J. Biol.
Chem. 272, 13 326–13 331. (doi:10.1074/jbc.272.
20.13326)
20. Russell DG. 2001 Mycobacterium tuberculosis: here
today, and here tomorrow. Nat. Rev. Mol. Cell. Biol.
2, 569–577. (doi:10.1038/35085034)
21. Tailleux L. et al. 2003 Constrained intracellular
survival of Mycobacterium tuberculosis in human
dendritic cells. J. Immunol. 170, 1939–1948.
(doi:10.4049/jimmunol.170.4.1939)
22. Vergne I, Chua J, Singh SB, Deretic V. 2004 Cell
biology of Mycobacterium tuberculosis phagosome.
Annu. Rev. Cell. Dev. Biol. 20, 367–394. (doi:10.
1146/annurev.cellbio.20.010403.114015)
23. Clemens DL, Horwitz MA. 1995 Characterization
of the Mycobacterium tuberculosis phagosome and
evidence that phagosomal maturation is inhibited.
J. Exp. Med. 181, 257–270. (doi:10.10.1084/jem.
181.1.257)
24. Anes E et al. 2006 Dynamic life and death
interactions between Mycobacterium smegmatis and
J774 macrophages. Cell Microbiol. 8, 939–960.
(doi:10.1111/j.1462-5822.2005.00675.x)
25. Bohsali A, Abdalla H, Velmurugan K, Briken V. 2010
The non-pathogenic mycobacteria M. smegmatis
and M. fortuitum induce rapid host cell apoptosis
via a caspase-3 and TNF dependent pathway. BMC
Microbiol. 10, 237. (doi:10.1186/1471-2180-10-237)
26. Byrd TF, Lyons CR. 1999 Preliminary characterization
of a Mycobacterium abscessus mutant in human
and murine models of infection. Infect Immun. 67,
4700–4707. (doi:10.0019-9567/99)
27. Oberley-Deegan RE, Lee YM, Morey GE, Cook DM, Chan
ED, Crapo JD. 2009 The antioxidant mimetic, MnTE-2-
PyP, reduces intracellular growth of Mycobacterium
abscessus. Am. J. Respir. Cell Mol. Biol. 41, 170–178.
(doi:10.1165/rcmb.2008-0138OC)
28. Nessar R, Reyrat J-M, Davidson LB, Byrd TF. 2011
Deletion of the mmpL4b gene in the Mycobacterium
abscessus glycopeptidolipid biosynthetic pathway
results in loss of surface colonization capability,
but enhanced ability to replicate in human
macrophages and stimulate their innate immune
response. Microbiology 157, 1187–1195. (doi:10.
1099/mic.0.046557-0)
29. Tomashefski JFJ, Stern RC, Demko CA, Doershuk CF.
1996 Nontuberculous mycobacteria in cystic
fibrosis. An autopsy study. Am. J. Respir. Crit.
Care Med. 154, 523–528. (doi:10.1164/ajrccm.
154.2.8756832)
30. Bernut A, Herrmann J-L, Kissa K, Dubremetz J-F,
Gaillard J-L, Lutfalla G, Kremer L. 2014 Mycobacterium
abscessus cording prevents phagocytosis and promotes
abscess formation. Proc. Natl Acad. Sci. USA 111,
E943–E952. (doi:10.1073/pnas.1321390111)
31. Catherinot E et al. 2007 Hypervirulence of a rough
variant of the Mycobacterium abscessus type strain.
Infect Immun. 75, 1055–1058. (doi:10.1128/IAI.
00835-06)
32. Riordan JR et al. 1989 Identification of the cystic
fibrosis gene: cloning and characterization of
complementary DNA. Science 245, 1066–1073.
(doi:10.1126/science.2475911)
33. Draper P. 1974 The mycoside capsule of
Mycobacterium avium 357. J. Gen. Microbiol. 83,
431–433. (doi:10.1099/00221287-83-2-431)
rsob.royalsocietypublishing.org
Open
Biol.
6:
160185
10
34. Medjahed H, Reyrat J-M. 2009 Construction of
Mycobacterium abscessus defined glycopeptidolipid
mutants: comparison of genetic tools. Appl. Environ.
Microbiol. 75, 1331–1338. (doi:10.1128/AEM.
01914-08)
35. Bernut A et al. 2016 Insights into the smooth-
to-rough transitioning in Mycobacterium bolletii
unravels a functional Tyr residue conserved in all
mycobacterial MmpL family members. Mol.
Microbiol. 99, 866–883. (doi:10.1111/mmi.13283)
36. Roux A-L et al. 2011 Overexpression of
proinflammatory TLR-2-signalling lipoproteins in
hypervirulent mycobacterial variants. Cell Microbiol.
13, 692–704. (doi:10.1111/j.1462-5822.2010.
01565.x)
37. Sturgill-Koszycki S et al. 1994 Lack of acidification in
Mycobacterium phagosomes produced by exclusion
of the vesicular proton-ATPase. Science 263,
678–681. (doi:10.1126/science.8303277)
38. Mwandumba HC, Russell DG, Nyirenda MH,
Anderson J, White SA, Molyneux ME, Squire. 2004
Mycobacterium tuberculosis resides in nonacidified
vacuoles in endocytically competent alveolar
macrophages from patients with tuberculosis and
HIV infection. J. Immunol. 172, 4592–4598.
(doi:10.4049/jimmunol.172.7.4592)
39. de Chastellier C, Forquet F, Gordon A, Thilo L. 2009
Mycobacterium requires an all-around closely
apposing phagosome membrane to maintain
the maturation block and this apposition is
re-established when it rescues itself from
phagolysosomes. Cell Microbiol. 11, 1190–1207.
(doi:10.1111/j.1462-5822.2009.01324.x)
40. Pethe K, Swenson DL, Alonso S, Anderson J, Wang
C, Russell DG. 2004 Isolation of Mycobacterium
tuberculosis mutants defective in the arrest of
phagosome maturation. Proc. Natl Acad. Sci. USA
101, 13 642–13 647. (doi:10.1073/pnas.
0401657101)
41. Yates RM, Hermetter A, Russell DG. 2005 The
kinetics of phagosome maturation as a function of
phagosome/lysosome fusion and acquisition of
hydrolytic activity. Traffic 6, 413–420. (doi:10.1111/
j. 1600-0854.2005.00284.x)
42. de Chastellier C. 2009 The many niches and
strategies used by pathogenic mycobacteria for
survival within host macrophages. Immunobiology
214, 526–542. (doi:10.1016/j.imbio.2008.12.005)
43. de Chastellier C, Thilo L. 1997 Phagosome
maturation and fusion with lysosomes in relation to
surface property and size of the phagocytic particle.
Eur. J. Cell Biol. 74, 49–62.
44. Pietersen R, Thilo L, de Chastellier C. 2004
Mycobacterium tuberculosis and Mycobacterium
avium modify the composition of the phagosomal
membrane in infected macrophages by selective
depletion of cell surface-derived glycoconjugates.
Eur. J. Cell Biol. 83, 153–158. (doi:10.1078/0171-
9335-00370)
45. Stamm LM et al. 2003 Mycobacterium marinum
escapes from phagosomes and is propelled by actin-
based motility. J. Exp. Med. 198, 1361–1368.
(doi:10.1084/jem.20031072)
46. van der Wel N, Hava D, Houben D, Fluitsma D, van
Zon M, Pierson J, Brenner M, Peters PJ. 2007
M. tuberculosis and M. leprae translocate from the
phagolysosome to the cytosol in myeloid cells. Cell
129, 1287–1298. (doi:10.1016/j.cell.2007.05.059)
47. Simeone R, Bobard A, Lippmann J, Bitter W,
Majlessi L, Brosch R, Enninga J. 2012 Phagosomal
rupture by Mycobacterium tuberculosis results in
toxicity and host cell death. PLoS Pathog. 8,
e1002507. (doi:10.1371/journal.ppat.1002507)
48. Dube´e V et al. 2015 b- Lactamase inhibition
by avibactam in Mycobacterium abscessus.
J. Antimicrob. Chemother. 70, 1051–1058.
(doi:10.1093/jac/dku510)
49. Huang J, Brumell JH. 2014 Bacteria–autophagy
interplay: a battle for survival. Nat. Rev. Microbiol.
12, 101–114. (doi:10.1038/nrmicro3160)
50. Zullo AJ, Lee S. 2012 Mycobacterial induction
of autophagy varies by species and occurs
independently of mammalian target of rapamycin
inhibition. J. Biol. Chem. 287, 12 668–12 678.
(doi:10.1074/jbc.M111.320135)
51. Bah A, Lacarrie`re C, Vergne I. 2016 Autophagy-
related proteins target ubiquitin-free mycobacterial
compartment to promote killing in macrophages.
Front. Cell Infect. Microbiol. 6, 53 (doi:10.3389/
fcimb.2016.00053)
52. Bryant JM, Grogono DM, Parkhill J, Floto RA. 2013
Transmission of M. abscessus in patients with cystic
fibrosis—authors’ reply. Lancet 382, 504. (London,
England). (doi:10.1016/S0140-6736(13)61709-2)
53. Davidson LB, Nessar R, Kempaiah P, Perkins DJ, Byrd
TF. 2011 Mycobacterium abscessus glycopeptidolipid
prevents respiratory epithelial TLR2 signaling as
measured by HD2 gene expression and IL-8 release.
PLoS ONE 6, e29148. (doi:10.1371/journal.pone.
0029148)
54. Baltierra-Uribe SL, de Garcı´a-Va´squez MJ, Castrejo´n-
Jime´nez NS, Estrella-Pin˜o´n MP, Luna-Herrera J,
Garcı´a-Pe´rez BE. 2014 Mycobacteria entry and
trafficking into endothelial cells. Can. J. Microbiol.
60, 569–577. (doi:10.1139/cjm-2014-0087)
55. Simeone R, Sayes F, Song O, Gro¨schel MI, Brodin P,
Brosch R, Majlessi L. 2015 Cytosolic access of
Mycobacterium tuberculosis: critical impact of
phagosomal acidification control and demonstration
of occurrence in vivo. PLoS Pathog. 11, e1004650.
(doi:10.1371/journal.ppat.1004650)
56. Deretic V, Saitoh T, Akira S. 2013 Autophagy in
infection, inflammation and immunity. Nat. Rev.
Immunol. 13, 722–737. (doi:10.1038/nri3532)
57. Hmama Z, Pen˜a-Dı´az S, Joseph S, Av-Gay Y. 2015
Immunoevasion and immunosuppression of the
macrophage by Mycobacterium tuberculosis.
Immunol. Rev. 264, 220–232. (doi:10.1111/imr.
12268)
58. Fratti RA, Chua J, Vergne I, Deretic V. 2003
Mycobacterium tuberculosis glycosylated
phosphatidylinositol causes phagosome maturation
arrest. Proc. Natl Acad. Sci. USA 100, 5437–5442.
(doi:10.1073/pnas.0737613100)
59. Corrales RM, Molle V, Leiba J, Mourey L, de
Chastellier C, Kremer L. 2012 Phosphorylation of
mycobacterial PcaA inhibits mycolic acid
cyclopropanation: consequences for intracellular
survival and for phagosome maturation block.
J. Biol. Chem. 287, 26 187–26 199. (doi:10.1074/
jbc.M112.373209)
60. Cambier CJ, Takaki KK, Larson RP, Hernandez RE, Tobin
DM, Urdahl KB, Cosma CL, Ramakrishnan L. 2014
Mycobacteria manipulate macrophage recruitment
through coordinated use of membrane lipids. Nature
505, 218–222. (doi:10.1038/nature12799)
61. Villeneuve C, Etienne G, Abadie V, Montrozier H,
Bordier C, Laval F, Daffe M, Maridonneau-Parini I,
Astarie-Dequeker C. 2003 Surface-exposed
glycopeptidolipids of Mycobacterium smegmatis
specifically inhibit the phagocytosis of mycobacteria
by human macrophages: identification of a novel
family of glycopeptidolipids. J. Biol. Chem. 278,
51 291–51 300. (doi:10.1074/jbc.M306554200)
62. Rhoades ER, Archambault AS, Greendyke R, Hsu F-F,
Streeter C, Byrd TF. 2009 Mycobacterium abscessus
glycopeptidolipids mask underlying cell wall
phosphatidyl-myo-inositol mannosides blocking
induction of human macrophage TNF-a by
preventing interaction with TLR2. J. Immunol. 183,
1997–2007. (doi:10.4049/jimmunol.0802181)
63. Frehel C, de Chastellier C, Lang T, Rastogi N. 1986
Evidence for inhibition of fusion of lysosomal and
prelysosomal compartments with phagosomes in
macrophages infected with pathogenic
Mycobacterium avium. Infect Immun. 52, 252–262.
64. Tereletsky MJ, Barrow WW. 1983 Postphagocytic
detection of glycopeptidolipids associated with the
superficial L1 layer of Mycobacterium intracellulare.
Infect Immun. 41, 1312–1321.
65. Shimada K, Takimoto H, Yano I, Kumazawa Y. 2006
Involvement of mannose receptor in
glycopeptidolipid-mediated inhibition of
phagosome-lysosome fusion. Microbiol. Immunol.
50, 243–251. (doi:10.1111/j.1348-0421.2006.
tb03782.x)
66. Kano H, Doi T, Fujita Y, Takimoto H, Yano I,
Kumazawa Y. 2005 Serotype-specific modulation of
human monocyte functions by glycopeptidolipid
(GPL) isolated from Mycobacterium avium complex.
Biol. Pharm. Bull. 28, 335–339. (doi:10.1248/bpb.
28.335)
67. Ripoll F et al. 2007 Genomics of glycopeptidolipid
biosynthesis in Mycobacterium abscessus and M.
chelonae. BMC Genomics 8, 114. (doi:10.1186/1471-
2164-8-114)
68. Harriff MJ, Wu M, Kent ML, Bermudez LE. 2008
Species of environmental mycobacteria differ in
their abilities to grow in human, mouse, and carp
macrophages and with regard to the presence of
mycobacterial virulence genes, as observed by DNA
microarray hybridization. Appl. Environ. Microbiol.
74, 275–285. (doi:10.1128/AEM.01480-07)
69. Kocincova D, Winter N, Euphrasie D, Daffe M, Reyrat
J-M, Etienne G. 2009 The cell surface-exposed
glycopeptidolipids confer a selective advantage to
the smooth variants of Mycobacterium smegmatis in
vitro. FEMS Microbiol. Lett. 290, 39–44. (doi:10.
1111/j.1574-6968.2008.01396.x)
rsob.royalsocietypublishing.org
Open
Biol.
6:
160185
11
70. Pawlik A et al. 2013 Identification and
characterization of the genetic changes responsible
for the characteristic smooth-to-rough morphotype
alterations of clinically persistent Mycobacterium
abscessus. Mol. Microbiol. 90, 612–629. (doi:10.
1111/mmi.12387)
71. Houben D et al. 2012 ESX-1-mediated translocation
to the cytosol controls virulence of mycobacteria.
Cell Microbiol. 14, 1287–1298. (doi:10.1111/j.1462-
5822.2012.01799.x)
72. Wassermann R et al. 2015 Mycobacterium
tuberculosis differentially activates cGAS- and
inflammasome-dependent intracellular
immune responses through ESX-1. Cell Host
Microbe 17, 799–810. (doi:10.1016/j.chom.2015.
05.003)
73. Wang J et al. 2015 Insights on the emergence
of Mycobacterium tuberculosis from the
analysis of Mycobacterium kansasii. Genome
Biol. Evol. 7, 856–870. (doi:10.1093/
gbe/evv035)
74. Bakala N’Goma JC et al. 2015 Mycobacterium
abscessus phospholipase C expression is induced
during coculture within amoebae and enhances M.
abscessus virulence in mice. Infect Immun. 83,
780–791. (doi:10.1128/IAI.02032-14)
75. Choo SW et al. 2014 Genomic reconnaissance of
clinical isolates of emerging human pathogen
Mycobacterium abscessus reveals high
evolutionary potential. Sci. Rep. 4, 4061. (doi:10.
1038/srep04061)
76. Sapriel G et al. 2016 Genome-wide mosaicism
within Mycobacterium abscessus: evolutionary and
epidemiological implications. BMC Genomics 17,
118. (doi:10.1186/s12864-016-2448-1)
77. Snouwaert JN, Brigman KK, Latour AM, Malouf NN,
Boucher RC, Smithies O. Koller BH. 1992 An animal
model for cystic fibrosis made by gene targeting.
Science 257, 1083–1088. (doi:10.1126/science.
257.5073.1083)
78. Colledge WH et al. 1995 Generation and
characterization of a delta F508 cystic fibrosis mouse
model. Nat. Genet. 10, 445–452. (doi:10.1038/
ng0895-445)
79. Dulphy N, Herrmann J-L, Nigou J, Rea D, Boissel N,
Puzo G, Charron D, Lagrange PH, Toubert A. 2007
Intermediate maturation of Mycobacterium
tuberculosis LAM-activated human dendritic cells.
Cell Microbiol. 9, 1412–1425. (doi:10.1111/j.1462-
5822.2006.00881.x)
80. Guerardel Y, Maes E, Briken V, Chirat F, Leroy Y,
Locht C, Strecker G, Kremer L. 2003 Lipomannan
and lipoarabinomannan from a clinical isolate of
Mycobacterium kansasii: novel structural features
and apoptosis-inducing properties. J. Biol. Chem.
278, 36 637–36 651. (doi:10.1074/jbc.
M305427200)
rsob.royalsocietypublishing.org
Open
Biol.
6:
160185
12
